только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 4 / 10
Страница 1 / 1

Список литературы

  1. Gardiner FW, McCuaig R, Arthur C, Carins T et al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review. // Obs. Med. 2019. Vol. 12(3):123–.
  2. Ovadia C., Williamson C. Intrahepatic cholestasis of pregnancy: Recent advances. // Clin. Dermatol. 2016. Vol. 34, № 3. P. 327-334.
  3. Geenes V. et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. // Hepatology. 2014. Vol. 59, № 4. P. 1482-1491.
  4. Gardiner FW, McCuaig R, Arthur C, Carins T M.A. al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review // Obs. Med. 2019. Vol. 12(3): 123-.
  5. Diken Z., Usta I.M., Nassar A.H. A clinical approach to intrahepatic cholestasis of pregnancy. // Am. J. Perinatal. 2014. Vol. 31, № 1. P. 1-8.
  6. Lindor K.D., Lee R.H. Intrahepatic cholestasis of pregnancy. I I UpToDate. 2019.
  7. Furrer R. et al. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. I I Obstet. Gynecol. 2016. Vol. 128, № 5. P. 1048-1052.
  8. Bicocca M.J., Sperling J.D., Chauhan S.P. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2018. Vol. 231. P. 180-187.
  9. Wikstrom Shemer E. et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. I I В JOG. 2013. Vol. 120, №6. P. 717-723.
  10. TOXNET Databases https://www.nlm.nih.gov/toxnet/index.html // Natl. Libr. Med. 2017.
  11. Успенская Ю.Б. Современное состояние проблемы холестаза беременных. // Проблемы женского здоровья. 2013. Vol. 8(3): 70-6.
  12. Wood A.M. et al. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. // Obstet. Gynecol. Surv. 2018. Vol. 73, № 2. P. 103-109.
  13. Reichert M.C., Lammert F. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum. // Semin. Liver Dis. 2018. Vol. 38, № 4. P. 299-307.
  14. Floreani A. et al. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis. H J. Matem. Fetal. Neonatal Med. 2013. Vol. 26, № 14. P. 1410-1415.
  15. Dixon P.H., Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. // Clin. Res. Hepatol. Gastroenterol. 2016. Vol. 40, № 2. P. 141-153.
  16. Sticova E., Jirsa M., Pawlowska J. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications. // Can. J. Gastroenterol. Hepatol. 2018. Vol. 2018. P. 2313675.
  17. Ивашкин B.T. et al. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени по диагностике и лечению холестаза. И Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015. Vol. 25, №2. P. 41-57.
  18. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. // Hepatology. 2008. Vol. 47, № 2. P. 376-379.
  19. Majewska A. et al. Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis. // Ginekol. Pol. 2019. Vol. 90, № 8. P. 458-463.
  20. Gen?osmano|lu Turkmen G. et al. Low serum vitamin D level is associated with intrahepatic cholestasis of pregnancy. // J. Obstet. Gynaecol. Res. 2018. Vol. 44, № 9. P. 1712-1718.
  21. Morton A., Laurie J. The biochemical diagnosis of intrahepatic cholestasis of pregnancy. // Obstet. Med. 2019. Vol. 12, № 2. P. 76-78.
  22. Herrera C.A. Diagnosis and Management of cholestasis. Pregnancy care. ECHO. April 8­th, 2016.
  23. Mitchell A. et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study // В JOG An Int. J. Obstet. Gynaecol. 2021. Vol. 128, №10. P. 1635-1644.
  24. Ovadia C. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta­analyses. // Lancet (London, England). 2019. Vol. 393, № 10174. P. 899-909.
  25. Cui D. et al. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. // J. Obstet. Gynaecol. Res. 2017. Vol. 43, № 9. P.1411-1420.
  26. Marschall H.-U. Management of intrahepatic cholestasis of pregnancy. // Expert Rev. Gastroenterol. Hepatol. 2015. Vol. 9, № 10. P. 1273-1279.
  27. Chappell L.C. et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. // Lancet (London, England). 2019. Vol. 394, № 10201. P. 849-860.
  28. Girling J., Knight C.L., Chappell L. Intrahepatic cholestasis of pregnancy // BJOG An Int. J. Obstet. Gynaecol. 2022. Vol. 129, № 13.
  29. Delgado Nunes V. et al. Intrapartum care of healthy women and their babies: summary of updated NICE guidance // BMJ. 2014. Vol. 349, № dec03 6. P. g6886-g6886.
  30. Batsry L. et al. Perinatal outcomes of intrahepatic cholestasis of pregnancy in twin versus singleton pregnancies: is plurality associated with adverse outcomes? // Arch. Gynecol. Obstet. 2019. Vol. 300, № 4. P. 881-887.
  31. Zhang Y. et al. Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis. // Hepat. Mon. 2016. Vol. 16, № 8. P. e38558.
  32. Kroumpouzos G., Cohen L.M. Specific dermatoses of pregnancy: an evidence-based systematic review. // Am. J. Obstet. Gynecol. 2003. Vol. 188, № 4. P. 1083-1092.
  33. Gtlney E., Ugar T. Effect of the fetal movement count on maternal-fetal attachment. // Jpn. J. Nuts. Sci. 2019. Vol. 16, № 1. P. 71-79.
  34. Matsubara S. et al. Perceived fetal movement count as a traditional but essential tool for evaluating fetal health: some additions and Japanese obstetricians’ and pediatricians’ view. // J. Matem. Fetal. Neonatal Med. 2018. Vol. 31, № 2. P. 251-252.
  35. Awad N.A. et al. Management and Outcome of Reduced Fetal Movements-is Ultrasound Necessary? I I J. Obstet. Gynaecol. Can. 2018. Vol. 40, № 4. P. 454-459.
  36. Flenady V. et al. Beyond the headlines: Fetal movement awareness is an important stillbirth prevention strategy. I I Women Birth. 2019. Vol. 32, № 1. P. 1-2.
  37. Heazell A.E.P. et al. Alterations in maternally perceived fetal movement and their association with late stillbirth: findings from the Midland and North of England stillbirth case-control study. 11BMJ Open. 2018. Vol. 8, № 7. P. e020031.
  38. Bryant J., Jamil R.T., Thistle J. Fetal Movement // StatPearls. 2019.
  39. Mangesi L. et al. Fetal movement counting for assessment of fetal wellbeing. // Cochrane database Syst. Rev. 2015. Vol. 15;(10):CD, № 10. P. CD004909.
  40. Heazell A.E.P. et al. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM). // BMJ Open. 2017. Vol. 7, № 8. P. e014813.
  41. Norman J.E. et al. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. // Lancet (London, England). 2018. Vol. 392, № 10158. P. 1629-1638.
  42. Fleminger J. et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial. // BJOG. 2021. Vol. 128, № 6. P. 1066-1075.
  43. Mashburn S. et al. Intrahepatic cholestasis of pregnancy: risk factors for severe disease. I I J. Matem. Fetal. Neonatal Med. 2022. Vol. 35, № 25. P. 8566-8570.
  44. Ovadia C, Seed FT, Sklavounos A G. V. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. // Lancet (London, England). 2019. Vol. 2;393(1017.
  45. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy. // World J. Gastroenterol. 2009. Vol. 15, № 17. P. 2049-2066.
  46. Mitchell A.L. et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. // BJOG. 2021. Vol. 128, № 10. P. 1635-1644.
  47. Jurate K. et al. Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy. // Ann. Hepatol. 2017. Vol. 16, № 4. P. 569-573.
  48. Maldonado M. et al. Intrahepatic Cholestasis of Pregnancy Leading to Severe Vitamin К Deficiency and Coagulopathy. // Case Rep. Obstet. Gynecol. 2017. Vol. 2017. P. 5646247.
  49. Olsson R. et al. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. // Gastroenterology. 1993. Vol. 105, № 1. P. 267-271.
  50. Ayta? S., Kargili A., Turkay C. A prolonged gestational intrahepatic cholestasis: a case report. // Turk. J. Gastroenterol. 2006. Vol. 17, № 3. P. 206-208.
  51. Mohr-Sasson A. et al. The Yield of Abdominal Ultrasound in the Evaluation of Elevated Liver Enzymes during the Second and the Third Trimester of Pregnancy. // Gynecol. Obstet. Invest. 2017. Vol. 82, № 5. P. 517-520.
  52. Heller M.T. et al. Imaging of hepatobiliary disorders complicating pregnancy. // AJR. Am. J. Roentgenol. 2011. Vol. 197, № 3. P. W528-36.
  53. Bacq Y., Sentilhes L. Intrahepatic cholestasis of pregnancy: Diagnosis and management. // Clin, liver Dis. 2014. Vol. 4, № 3. P. 58-61.
  54. Liu X. et al. Perinatal outcomes with intrahepatic cholestasis of pregnancy in twin pregnancies. //J. Matem. Fetal. Neonatal Med. 2016. Vol. 29, № 13. P. 2176-2181.
  55. Koshida S. et al. Fetal movement frequency and the effect of associated perinatal factors: Multicenter study. // Women Birth. 2019. Vol. 32, № 2. P. 127-130.
  56. Joshi D. et al. Liver disease in pregnancy. // Lancet (London, England). 2010. Vol. 375, № 9714. P. 594-605.
  57. Chappell L.C. et al. Does ursodeoxycholic acid improve perinatal outcomes m women with intrahepatic cholestasis of pregnancy? // BMJ. 2018. Vol. 360. P. kl04.
  58. Kong X. et al. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). // Medicine (Baltimore). 2016. Vol. 95, № 40. P. e4949.
  59. Gurung V. et al. Interventions for treating cholestasis in pregnancy. // Cochrane database Syst. Rev. 2013. Vol. 6, № 6. P. CD000493.
  60. Shen Y. et al. Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis. // Clin. Drug Investig. 2019. Vol. 39, № l.P. 15-26.
  61. Joutsiniemi T. et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial. // Arch. Gynecol. Obstet. 2014. Vol. 289, № 3. P. 541-547.
  62. Parizek A. et al. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. // Ann. Hepatol. 2016. Vol. 15, № 5. P. 757-761.
  63. Pusl T., Beuers U. Intrahepatic cholestasis of pregnancy. // Orphanet J. Rare Dis. 2007. Vol. 2. P. 26.
  64. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. // Ann. Hepatol. 2002. Vol. 1, № 1. P. 20-28.
  65. Bacq Y. et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. // Gastroenterology. 2012. Vol. 143, № 6. P. 1492-1501.
  66. Chappell L.C. et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. // BMJ. 2012. Vol. 344. P. e3799.
  67. Zhou F. et al. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy]. I I Zhonghua Gan Zang Bing Za Zhi. 2014. Vol. 22, № 4. P. 299-304.
  68. Wunsch E. et al. Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study. // J. Gastrointestin. Liver Dis. 2018. Vol. 27, № 3. P. 273-279.
  69. Girling J. et al. Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022. // В JOG. 2022. Vol. 129, № 13. P. e95-el14.
  70. Reyes H. et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. // Gastroenterology. 1987. Vol. 93, № 3. P. 584-590.
  71. Сидоркевич C.B. В.В.А.В.В.В.И.Д.О. Эфферентные и кровесберегающие технологии в перинатологии. Информ-Навигатор, 2014. 351 р.
  72. Кузнецов В.П. Тактика ведения беременных с преэклампсией, осложненной нарушением метаболической функции печени и синдромом эндогенной интоксикации // Автореф. дисс. д-ра мед. наук. 2015. Р. 51.
  73. Nielsen J.H., Lykke J.A. Differentiated timing of induction for women with intrahepatic cholestasis of pregnancy-A historical cohort study. // Acta Obstet. Gynecol. Scand. 2021. Vol. 100, №2. P. 279-285.
  74. Frank Z.C. et al. Timing of Delivery in Intrahepatic Cholestasis of Pregnancy With Total Bile Acids 40-99 pmol/L // Obstet. Gynecol. 2020. Vol. 135. P. 156S..
  75. Webster J.R. et al. Operative delivery rates following induction of labour for obstetric cholestasis. // Obstet. Med. 2011. Vol. 4, № 2. P. 66-69.
  76. de Pagter A.G. et al. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? // Gastroenterology. 1976. Vol. 71, № 2. P. 202-207.
  77. Šimják P. et al. Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk //Scientific Reports. – 2022. – Т. 12. – №. 1. – С. 19543
  78. Cui D. et al. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: a meta‐analysis //Journal of Obstetrics and Gynaecology Research. – 2017. – Т. 43. – №. 9. – С. 1411-1420.
  79. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev. 2017; 3:CD004454.
  80. Rubagumya D. et al. Intrahepatic cholestasis of pregnancy: Case series of a rare disease in an African setting //SAGE Open Medical Case Reports. – 2022. – Т. 10. – С. 2050313X221105832.
  81. Edoo A. W. I. et al. A case report of early onset intrahepatic cholestasis of pregnancy //Archives of Disease in Childhood-Fetal and Neonatal Edition. – 2012. – Т. 97. – №. Suppl 1. – С. A63-A63.
  82. Binder, T., Salaj, P., Zima, T., & Vítek, L. (2006). Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. Journal of Perinatal Medicine, 34(5). doi:10.1515/jpm.2006.077